BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2018
View Archived Issues
Aldeyra Therapeutics, Janssen enter systemic inflammatory disease collaboration
Read More
BMS licenses Domain Therapeutics' bioSens-All technology
Read More
IL17F His161Arg gene polymorphism found positively associated with psoriasis
Read More
EMA grants orphan drug designation to cannabidiol for tuberous sclerosis
Read More
Beacon Discovery enters GPCR drug discovery collaboration with Takeda
Read More
Intensity Therapeutics reports data from phase I/II study of INT-230-6
Read More
EMA gives accelerated assessment to Shire's lanadelumab
Read More
Mannose-binding lectin tied to influenza-associated critical illness in children
Read More
Cereblon gene knockout mimics autosomal recessive non-syndromic intellectual disability
Read More
PhaseBio Pharmaceuticals receives NIH grant to support PB-1046 development
Read More
Dyadic enters funded proof-of-concept research collaboration with Mitsubishi Tanabe
Read More
Novo Nordisk submits regulatory applications for N8-GP in U.S. and E.U.
Read More
Dendritic cell-based DNA vaccine effectively protects against herpes simplex virus keratitis in vivo
Read More
FDA accepts Tetraphase's NDA for eravacycline
Read More
Orphelia Pharma announces MAA filing for Kigabeq
Read More
Ophthotech, University of Massachusetts collaborate on novel gene therapies for ophthalmic diseases
Read More
Shanghai De Novo Pharmatech divulges new IDO1 inhibitors
Read More
Cynata reports updated data from phase I trial of CYP-001 in steroid-resistant GvHD
Read More
European Commission approves Hemlibra
Read More
Zafgen presents novel MetAP 2 inhibitors
Read More
RWTH Aachen discloses novel ATR kinase inhibitors
Read More
FDA accepts Shire's BLA for calaspargase pegol
Read More
Quentis Therapeutics completes series A financing to advance first-in-class immunotherapies
Read More
SK Chemicals and Sanofi patent vaccine compositions for streptococcal infection
Read More
Reata updates timeline for bardoxolone methyl studies in rare forms of chronic kidney disease
Read More
Senti Biosciences closes series A financing to develop gene and cell-based therapies
Read More
Novel anti-PD-1 antibodies presented by Y-Biologics
Read More
Abbott and Surmodics enter agreement for SurVeil drug-coated balloon
Read More
Phase III study of Hisamitsu's HP-3000 transdermal patch meets primary endpoint
Read More
Celgene receives FDA refusal to file letter for ozanimod NDA in relapsing MS
Read More
TRPM4 gene polymorphisms associated with cerebral edema in TBI patients
Read More
Reminder -- we want your opinion on TRDN
Read More